CIK 0001082554 · Large accelerated filer
UNITED THERAPEUTICS Corp
Sign in to watch- Ticker
- UTHR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 521984749
- Phone
- 3016089292
- Business address
- 1000 SPRING ST, SILVER SPRING, MD, 20910
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $347,711,405
- in 75 filings, $346.9M under 10b5-1 plans
Net −$347,711,405. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise 10b5-1 | +8,300 | $146.03 | $1.2M | 53,472 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,579 | $495.97 | $783K | 51,893 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −2,873 | $496.58 | $1.4M | 49,020 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,400 | $497.54 | $697K | 47,620 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −843 | $498.74 | $420K | 46,777 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −1,160 | $499.75 | $580K | 45,617 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −125 | $500.80 | $63K | 45,492 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Sale 10b5-1 | −320 | $501.58 | $161K | 45,172 |
| 2026-09-17 | MAHON PAUL A EVP & GENERAL COUNSEL | Option exercise · Stock Option 10b5-1 | −8,300 | 47,540 | ||
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise 10b5-1 | +9,500 | $117.76 | $1.1M | 333,943 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −599 | $493.22 | $295K | 333,344 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,750 | $494.34 | $865K | 331,594 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,905 | $495.11 | $943K | 329,689 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −2,182 | $496.21 | $1.1M | 327,507 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −1,953 | $497.17 | $971K | 325,554 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −151 | $497.79 | $75K | 325,403 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −332 | $499.10 | $166K | 325,071 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −468 | $500.09 | $234K | 324,603 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Sale 10b5-1 | −160 | $501.60 | $80K | 324,443 |
| 2026-09-17 | ROTHBLATT MARTINE A Chairperson & CEO | Option exercise · Stock Option 10b5-1 | −9,500 | 413,910 |
Page 35 of 121 · 2,404 trades